02 May Recommended Calculations of Contraception Duration after Completion of Therapy to Minimise The Risk Of Embryotoxicity and Teratogenicity Associated with the use of Genotoxic Anticancer Medicines (Including Potential Metabolites).
Posted at 06:29h
in
In collaboration with the South African Health Products Regulatory Authority (SAHPRA), the companies listed below would like to inform you about recommended calculations of contraception duration after completion of therapy with genotoxic anticancer medicines (including potential metabolites).
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
29/04/2024
File Type:
pdf
Category:
Communication To Health Care Professionals